
Amide Technologies
Accelerating drug development with rapid peptide synthesis and high-speed delivery.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
* | $7.5m | Series A | |
Total Funding | 000k |
AmideTech operates in the pharmaceutical and biotechnology sectors, specializing in the synthesis of complex peptides and proteins. The company serves pharmaceutical companies, research institutions, and biotech firms that require high-quality peptides for drug discovery and development. AmideTech's business model focuses on providing custom peptide synthesis services, including the production of long polyamides and full-length proteins. The company differentiates itself by accepting challenging orders that other vendors refuse and delivering them in less than a week, thus accelerating the drug development process. Revenue is generated through the sale of these specialized peptide synthesis services. AmideTech's competitive advantage lies in its ability to produce significantly longer peptides and its commitment to high-speed delivery, which is critical in the fast-paced world of drug discovery. The company also emphasizes a collaborative and transparent work culture, attracting highly motivated scientists and engineers to its team.
Keywords: peptide synthesis, drug development, biotechnology, pharmaceutical, custom peptides, rapid delivery, polyamides, protein ligation, research institutions, biotech firms.